CoQ10 research. Every three years, the International Coenzyme Q10 Association (ICQA) holds an international conference. Speakers at the 10th conference of the ICQA held in Hamburg, Germany, May 12-15, 2022, made the following presentations:

Coenzyme Q10 and Ageing
- An ageing-related decrease in growth hormone and insulin-like growth factor 1 result in an increase in sub-clinical inflammation. Coenzyme Q10 levels in organs, except in the liver, decline by approximately 50% in elderly individuals. The decrease in growth hormone and IGF-1 and the decline in Coenzyme Q10 in organs are inter-related [K. Brismar].
- The biological mechanisms underlying the reduction in cardiovascular mortality and the improvement in heart function seen in senior citizens supplemented with a combination of Coenzyme Q10 and selenium in the KiSel-10 Study include the following [U. Alehagen]:
- reduced systemic inflammation
- improved endothelial dysfunction
- reduced fibrosis
- Research has confirmed that combined CoQ10 and selenium supplementation is associated with longer telomere length, compared to placebo supplementation [U. Alehagen]. Note: Telomere length is a bio-marker for ageing.
Coenzyme Q10 and Bioavailability
The comparison of the results from different CoQ10 absorption and bioavailability studies is ill-advised because the results are based on different study protocols, different study groups, different formulations and different dosages of Coenzyme Q10, different modes of administration (fasting/non-fasting), different blood sampling techniques, and different observation times [I. Pravst].